zhjmedical.com (ZJYL) Long-Term Liabilities to Equity

Corporate emblem and logo of Jin Medical (ZJYL)

Jin Medical International sales rely on an aging population and the accessibility of medical care. Rising logistics costs and currency risks are putting pressure on the business. However, its own distribution network and integration into China's insurance system strengthen the company's position. The long-term financial leverage ratio helps assess the firm's independence, and 0.09 becomes the new value of the indicator on this chart.

ZJYL zhjmedical.com: Long-Term Debt to Capital in the range 02/21/2024 - 11/01/2026
Manufactured product of Jin Medical International Ltd.

This ratio measures the proportion of borrowings with a maturity exceeding one year relative to equity, determining the degree of financial stability and debt load risk. For Jin Medical International (ZJYL), stable demand for rehabilitation equipment allows for the optimization of its capital structure. An analysis of the long-term debt-to-equity ratio reveals a balance between debt-funded growth and financial autonomy. Reducing leverage strengthens the business, although excessive caution may limit expansion rates. Investors should view this trend as an indicator of the company's solvency over a long-term cycle.

Key competitors

Boston Scientific Corp (BSX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Edwards Lifesciences Corp (EW)|RMD: Long-Term Liabilities to Equity|Long-Term Debt to Capital PODD (Insulet Corporation)|Zimmer (ZBH) - Long-Term Liabilities to Capital|CooperCompanies - Long-Term Debt to Capital|Invisalign (ALGN) - Long-Term Debt to Equity Ratio|GMED: Long-Term Debt to Capital|TMDX - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital artivion.com|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity IART (Integra LifeSciences Corp)|Long-Term Debt to Capital ESTA (Motiva)|Ratio of Long-Term Indebtedness to Capital iLet Bionic Pancreas (BBNX)|IRMD: Long-Term Debt to Equity Ratio|Long-Term Liabilities to Equity EMBC|TNDM: Long-Term Debt to Capital|Long-Term Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Long-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|SRTA - Long-Term Debt to Equity Ratio|Carlsmed Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital RxSight Ophthalmic|CLPT: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio STXS|STIM (Neuronetics) - Long-Term Debt to Capital|Sight Sciences Inc. (SGHT) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital OBIO|Long-Term Debt to Equity Ratio anikatherapeutics.com ANIK|Long-Term Debt to Capital NSPR (InspireMD, Inc.)|Long-Term Debt to Capital Vivani Medical Inc VANI|XTNT - Long-Term Debt to Equity|NMTC: Long-Term Debt to Equity|MODD (modular-medical.com) - Long-Term Debt to Equity Ratio|Myomo Inc - Long-Term Debt to Capital Coefficient|COCH (Envoy Medical, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital vivoslife.com VVOS|Long-Term Debt to Equity enVVeno Medical Corp. (NVNO)|sintx.com (SINT) - Long-Term Indebtedness to Equity|Tenon Medical, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Lifeward Ltd. LFWD|Autonomix - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital invobioscience.com IVF|Bone Biologics Corp (BBLG) - Long-Term Debt to Equity|Long-Term Liabilities to Equity AXNX (Axonics Inc.)|Long-Term Debt to Equity Biolase, Inc.|Long-Term Debt to Equity Ratio Dynatronics Corp. (DYNT)|Long-Term Debt to Capital FNA|INVO - Long-Term Liabilities to Capital